Literature DB >> 20811666

Increased apoptosis and decreased proliferation of colonic epithelium in dextran sulfate sodium-induced colitis in mice.

Yoshio Araki1, Ken-ichi Mukaisyo, Hiroyuki Sugihara, Yoshihide Fujiyama, Takanori Hattori.   

Abstract

The pathogenic mechanisms responsible for inflammatory bowel disease, especially ulcerative colitis (UC), are poorly understood. In animal models, the oral administration of dextran sulfate sodium (DSS) induces colitis, which exhibits several clinical and histological features similar to UC. In addition, the longstanding administration of DSS also induces colon cancer. However, the pathogenic factors responsible for DSS-induced colitis and the subsequent colon cancer also remain unclear. In particular, there are only limited data concerning colonic epithelia cell apoptosis and proliferation in DSS-induced colitis. Therefore, we investigated the relationships between these factors. Colitis was induced in BALB/cA Jcl mice by 8 days of oral administration of standard diets containing 5% (w/w of diet) DSS. The control mice received the standard diets only. Morphological changes in the colonic mucosa were evaluated and scored by light microscopy. Apoptosis was studied by the TUNEL assay, and cell proliferation by Ki-67 immunoreactivity. The macroscopic findings showed the most severe inflammation in the distal colon. Epithelial apoptosis increased approximately 5-fold after DSS administration as compared to the controls. On the other hand, the mitotic cells decreased about half-fold as compared to the controls. Ki-67 immunohistochemistry showed that cells with cell cycle arrest at the G0 stage in the crypt increased approximately 2-fold as compared to the controls. In conclusion, the increased apoptosis and decreased proliferation might lead to a breakdown of the epithelial barrier function, and thus facilitate the mucosal invasion of intraluminal microorganisms in DSS-induced colitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20811666     DOI: 10.3892/or.2010.869

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  56 in total

Review 1.  The Role of Neuropeptides in Mouse Models of Colitis.

Authors:  David Padua; John P Vu; Patrizia M Germano; Joseph R Pisegna
Journal:  J Mol Neurosci       Date:  2015-12-08       Impact factor: 3.444

2.  C/EBP homologous protein inhibits tissue repair in response to gut injury and is inversely regulated with chronic inflammation.

Authors:  N Waldschmitt; E Berger; E Rath; R B Sartor; B Weigmann; M Heikenwalder; M Gerhard; K-P Janssen; D Haller
Journal:  Mucosal Immunol       Date:  2014-05-21       Impact factor: 7.313

3.  MicroRNA-193a-3p Reduces Intestinal Inflammation in Response to Microbiota via Down-regulation of Colonic PepT1.

Authors:  Xin Dai; Xi Chen; Qun Chen; Lei Shi; Hongwei Liang; Zhen Zhou; Qian Liu; Wenjing Pang; Dongxia Hou; Cheng Wang; Ke Zen; Yaozong Yuan; Chen-Yu Zhang; Lu Xia
Journal:  J Biol Chem       Date:  2015-04-30       Impact factor: 5.157

4.  Exacerbated experimental colitis in TNFAIP8-deficient mice.

Authors:  Honghong Sun; Yunwei Lou; Thomas Porturas; Samantha Morrissey; George Luo; Ji Qi; Qingguo Ruan; Songlin Shi; Youhai H Chen
Journal:  J Immunol       Date:  2015-05-06       Impact factor: 5.422

5.  Calcium/calmodulin-dependent protein kinase IV (CaMKIV) activation contributes to the pathogenesis of experimental colitis via inhibition of intestinal epithelial cell proliferation.

Authors:  Kellie E Cunningham; Elizabeth A Novak; Garret Vincent; Vei Shaun Siow; Brian D Griffith; Sarangarajan Ranganathan; Matthew R Rosengart; Jon D Piganelli; Kevin P Mollen
Journal:  FASEB J       Date:  2018-08-16       Impact factor: 5.191

6.  Intestinal E-cadherin Deficiency Aggravates Dextran Sodium Sulfate-Induced Colitis.

Authors:  Jessica I Grill; Jens Neumann; Felix Hiltwein; Frank T Kolligs; Marlon R Schneider
Journal:  Dig Dis Sci       Date:  2015-01-30       Impact factor: 3.199

7.  Non-Hematopoietic β-Arrestin1 Confers Protection Against Experimental Colitis.

Authors:  Taehyung Lee; Eunhee Lee; David Arrollo; Peter C Lucas; Narayanan Parameswaran
Journal:  J Cell Physiol       Date:  2015-11-20       Impact factor: 6.384

Review 8.  Animal models of inflammatory bowel disease: a review.

Authors:  Nidhi Goyal; Ajay Rana; Abhilasha Ahlawat; Krishna Reddy V Bijjem; Puneet Kumar
Journal:  Inflammopharmacology       Date:  2014-06-07       Impact factor: 4.473

9.  Tauroursodeoxycholic acid inhibits experimental colitis by preventing early intestinal epithelial cell death.

Authors:  Debby Laukens; Lindsey Devisscher; Lien Van den Bossche; Pieter Hindryckx; Roosmarijn E Vandenbroucke; Yves-Paul Vandewynckel; Claude Cuvelier; Brigitta M Brinkman; Claude Libert; Peter Vandenabeele; Martine De Vos
Journal:  Lab Invest       Date:  2014-10-13       Impact factor: 5.662

10.  Role of far upstream element binding protein 1 in colonic epithelial disruption during dextran sulphate sodium-induced murine colitis.

Authors:  Qiyun Tang; Weiwei Xia; Qianqian Ji; Runzhou Ni; Jian'an Bai; Liren Li; Yongwei Qin
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.